Home » Topics » BioWorld Science

BioWorld Science
RSS

Clinical trial authorization received in U.K. to initiate phase I study with OLX-10010

May 30, 2018

Xalkori receives FDA breakthrough therapy designation in two new indications

May 30, 2018

Tavalisse becomes available in the U.S.

May 30, 2018

AhR antagonist PX-A24590 shows efficacy in pancreatic tumor model

May 30, 2018

Phase III IMpower130 study of Tecentriq in NSCLC meets coprimary endpoints

May 29, 2018

Pfizer seeks Japanese approval of dacomitinib for EGFR mutation-positive NSCLC

May 29, 2018

Researchers discover new targets for lymphoblastic leukemia immunotherapy

May 29, 2018

Kowa to launch Parmodia in Japan for hyperlipidemia

May 29, 2018

Japanese approval sought for Trelegy Ellipta

May 29, 2018

Chugai seeks Japanese approval for Actemra for cytokine release syndrome

May 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...